Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00620139 · ClinicalTrials.gov registry record

Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
17
Enrollment target

NCT00620139: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00620139 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00620139 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
17 participants
Enrollment target

Study Summary

This pilot study seeks to evaluate the feasibility of measuring the proximal effects of concurrent chemoradiotherapy (CRT) on the expression of potential therapeutic target molecules in Head and Neck Squamous Cell Carcinoma (HNSCC). Specifically, this study proposes to evaluate the extent to which CRT induces the differential expression of components along two critical, and potentially interdependent, molecular pathways: the arachidonic acid and epidermal growth factor receptor (EGFR) signaling pathways.

Interventions

  • BIOLOGICAL the arachidonic acid and EGFR signaling pathways and their interaction in HNSCC tumorigenesis,

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2005-03
Est. Completion 2013-10
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00620139 record still lists

NCT00620139 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which the arachidonic acid and EGFR signaling pathways and their interaction in HNSCC tumorigenesis, is the first listed.

NCT00620139 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00620139 about?

NCT00620139 is a clinical study titled "Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma". This pilot study seeks to evaluate the feasibility of measuring the proximal effects of concurrent chemoradiotherapy (CRT) on the expression of potential therapeutic target molecules in Head and Neck Squamous Cell Carcinoma (HNSCC). Specifically, this study proposes to evaluate the extent to which C...

What is the current status of trial NCT00620139?

This trial is currently completed. The enrollment target is 17 participants. The study started on 2005-03. Estimated completion is 2013-10.

What interventions are being tested in trial NCT00620139?

The interventions under investigation include: the arachidonic acid and EGFR signaling pathways and their interaction in HNSCC tumorigenesis, (BIOLOGICAL).

Who is sponsoring clinical trial NCT00620139?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00620139, the US trial registry maintained by the National Library of Medicine. NCT00620139 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.